SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-10-002273
Filing Date
2010-01-20
Accepted
2010-01-20 16:19:08
Documents
5
Period of Report
2010-01-14
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a10-2134_18k.htm 8-K 29190
2 EX-99.1 a10-2134_1ex99d1.htm EX-99.1 28515
3 EX-99.2 a10-2134_1ex99d2.htm EX-99.2 36905
4 GRAPHIC g21341mmi001.jpg GRAPHIC 6475
5 GRAPHIC g21341moi001.jpg GRAPHIC 6475
  Complete submission text file 0001104659-10-002273.txt   114327
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 10536487
SIC: 2834 Pharmaceutical Preparations